Salicylic acid 4% / Phenol 2.5% / Pyrogallol 2.5% in White Soft Paraffin
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 29 studies.
Reviews & meta-analyses: 3 · 1995–2025
Showing all 29 studies, sorted by most relevant.
Anket Sharma, S. Kohli, Kanika Khanna, et al.
Journal of Plant Growth Regulation, 2023
Xiangzhi Meng, Jia-Long Fang, M. Fu, et al.
Horticulturae, 2023
Postharvest diseases cause huge postharvest losses of horticultural fresh produce. Cooling and synthetic fungicide are used as traditional postharvest preservation technology. Recently, induced resistance has been thought to be an optional and perhaps alternative preservation technology. 1-methylcyclopropylene (1-MCP) and salicylic acid (SA) are two more common chemical agents used mostly as a preservative for harvested fruit in order to achieve better quality and better taste. Many reports have also proven that 1-MCP and SA could induce postharvest fruit resistance. The purpose of this review is to summarize the role of 1-MCP and SA in postharvest fruit resistance, including the effect of 1-MCP and SA on the induced resistance as well as its involved mechanism; the effects of 1-MCP and SA on firmness, phenolic metabolism, membrane lipid metabolism, and reactive oxygen species in fruit after harvest; and the effects of 1-MCP and SA on disease resistance-related defense enzymes, proteins, signaling synthesis, and signaling pathways as well as the combined effect of 1-MCP and SA on the induced resistance and its mechanism. Meanwhile, we prospect for the future direction of increasing postharvest fruit resistance by 1-MCP and SA in more depth.
Abstract licence: CC BY
Yuanyuan Ding, B. Fan, Cheng Zhu, et al.
Cells, 2023
- Plants
- Salicylic Acid
- Aspirin
Salicylic acid (SA) is a phenolic compound produced by all plants that has an important role in diverse processes of plant growth and stress responses. SA is also the principal metabolite of aspirin and is responsible for many of the anti-inflammatory, cardioprotective and antitumor activities of aspirin. As a result, the number of identified SA targets in both plants and humans is large and continues to increase. These SA targets include catalases/peroxidases, metabolic enzymes, protein kinases and phosphatases, nucleosomal and ribosomal proteins and regulatory and signaling proteins, which mediate the diverse actions of SA in plants and humans. While some of these SA targets and actions are unique to plants or humans, many others are conserved or share striking similarities in the two types of organisms, which underlie a host of common biological processes that are regulated or impacted by SA. In this review, we compare shared and related SA targets and activities to highlight the common nature of actions by SA as a hormone in plants versus a therapeutic agent in humans. The cross examination of SA targets and activities can help identify new actions of SA and better explain their underlying mechanisms in plants and humans.
Abstract licence: CC BY
C Scheck
Water Research, 1995
Sundas Tanveer, N. Akhtar, N. Ilyas, et al.
Heliyon, 2023
This research was designed to analyze the interactive effects of Pseudomonas putida and salicylic acid on the growth of canola in stress and non-stress conditions. Salicylic acid is a phenolic derivative, that has a direct involvement in various plant stages like growth, and inflorescence. While Pseudomonas putida is a drought-tolerant strain having plant growth-promoting characteristics like phosphate solubilization, indole acetic acid, and catalase production. Combined application of Pseudomonas putida and salicylic acid has the ability to develop stress tolerance in plants and also improve growth of plants. They have significant (p < 0.05) effects on germination and morphological, physiological, and biochemical parameters. The plants that received the co-application of Pseudomonas putida and salicylic acid gave more significant results than their alone application. They showed enhanced germination percentage, germination index, promptness index and, seedling vigor index by 19%, 18%, 34% and, 27%, respectively. There was a substantial increase of 25%, 27%, and 39% in shoot length, root length, and leaf area, respectively. The synergistic effect of both treatments has caused a 14% and 12% increase in the Canola plants' relative water content and membrane stability index respectively. A substantial increase of 18% in proline content was observed by the inoculation of Pseudomonas putida, whereas proline content was increased by 28% by the exogenous application of salicylic acid. The content of flavonoids (39%) and phenol (40%) was significantly increased by the co-application. The increase in superoxide dismutase (46%), ascorbate peroxidase (43%), and glutathione (19%) were also significant. The present research demonstrated that the combined application of Pseudomonas putida and salicylic acid induces drought tolerance in canola and significantly improves its growth.
Abstract licence: CC BY-NC-ND
Nyanthanglo Woch, Supriya Laha, Padmaja Gudipalli
In Vitro Cellular & Developmental Biology - Plant, 2023
Puja Ghosh, Aryadeep Roychoudhury
Brazilian Journal of Botany, 2024
Xinling Zhang, Yuxing Liu, Weida Zhang, et al.
Foods, 2024
The potential of salicylic acid (SA) in delaying postharvest fruit senescence has been extensively documented; nevertheless, its effect on antioxidant activity and quality of ‘France’ prune fruit is largely unknown. The study investigated the effects of SA (0.5 mM) on postharvest quality deterioration of ‘France’ prune fruit. Results indicated that SA impeded the increase in respiration rate and weight loss, and mitigated the decrease of soluble solids content (SSC), titratable acidity (TA) content, firmness, and hue angle. SA sustained the ascorbate-glutathione cycle by inducing the production of ascorbic acid (AsA) and glutathione (GSH) and attenuates flavonoids, total phenols, and anthocyanins degradation by inhibiting polyphenol oxidase (PPO) activity and PdPPO. Moreover, SA significantly improved superoxide dismutase (SOD), catalase (CAT), ascorbate peroxidase (APX), peroxidase (POD), and glutathione reductase (GR) activities and gene expression levels, sustained higher 2,2′-Azinobis-(3-ethylbenzthiazoline-6-sulphonate) (ABTS) and 1,1-diphenyl-2-picryl-hydrazyl (DPPH) free radical scavenging capacity, ferric reducing antioxidant power (FRAP), and hydroxyl radical (·OH) inhibition capacity, and impeded the production of hydrogen peroxide (H2O2) and superoxide anion (O2•−). Overall, SA improved the antioxidant capacity by inducing the synthesis of defense response-related substances and promoting antioxidant enzyme activities to sustain the storage quality of ‘France’ prune fruit.
Abstract licence: CC BY
Meiling Ding, Yongfeng Xie, Yuhang Zhang, et al.
Journal of experimental botany, 2023
- Plant Proteins
- Salvia miltiorrhiza
- Gene Expression Regulation, Plant
T. Adhikary, P. Gill, S. K. Jawandha, et al.
Journal of the science of food and agriculture, 2020
- Cold Temperature
- Color
- Catechol Oxidase
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.